Needle-free vaccine delivery platforms can solve the problems of stockpiling, cold-chain management, and pandemic preparedness.
Timothy Sullivan
Advertisement
Timothy Sullivan is the president and CEO at Mystic Pharmaceuticals, Inc.
Articles by Timothy Sullivan
Advertisement
Latest Updated Articles
Innovations in Intranasal Vaccine Delivery TechnologyPublished: October 1st 2009 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
RNAnalytics CPHI Interview, Part Two: Nanoparticle Case Studies and Response to US mRNA Pullback
2
How Is AI Transforming Biomanufacturing and Biopharma Workforce Training?
3
How Enzymatic Platforms May Change the Therapeutic RNA Supply Chain
4
Achieving Real Impact Navigating the Data and Regulatory Barriers to AI Adoption in Bio/pharma
5
